AnaptysBio, Inc. (ANAB) Tops Q1 EPS by 2c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.28), $0.02 better than the analyst estimate of ($1.30).

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Werner Enterprises (WERN) PT Raised to $40 at Stifel
• Stifel Reiterates Buy Rating on Wolverine World Wide (WWW)